Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

Drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

Resource Type

CF Research News

Authors

Yifat S Oren, Michal Irony-Tur Sinai, Anita Golec, Ofra Barchad-Avitzur, Venkateshwar Mutyam, Yao Li, Jeong Hong, Efrat Ozeri-Galai, Aurélie Hatton, Chen Leibson, Liran Carmel, Joel Reiter, Eric J Sorscher, Steve D Wilton, Eitan Kerem, Steven M Rowe, Isab

References

J Cyst Fibros. 2021 Sep;20(5):865-875. doi: 10.1016/j.jcf.2021.06.003. Epub 2021 Jul 2.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

CFTR/Basic Science [3]

Keywords

3849+10 kb C-to-T mutation [4]
Antisense oligonucleotides [5]
drug development [6]
Splicing modulation [7]

Date

Monday, September 20, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/drug-development-cystic-fibrosis-patients-carrying-384910kb-c-t

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00091R1_FINAL_Kerem_091021.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34226157/ [3] https://www.ecfs.eu/research-article-themes/cftrbasic-science [4] https://www.ecfs.eu/research-article-keywords/384910-kb-c-t-mutation [5] https://www.ecfs.eu/research-article-keywords/antisense-oligonucleotides [6] https://www.ecfs.eu/research-article-keywords/drug-development [7] https://www.ecfs.eu/research-article-keywords/splicing-modulation [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines